Trial · NCT07909980
Impact Of Aerobic Exercise on Sleep Quality and Postural Control Interplay Among University Students
NCT07909980, Not applicable, Not yet recruiting, Cairo University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Impact Of Aerobic Exercise on Sleep Quality and Postural Control Interplay Among University Students. Trials, record NCT07909980. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909980
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact Of Aerobic Exercise on Sleep Quality and Postural Control Interplay Among University Students
- NCT number
- NCT07909980
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 66 participants, estimated
- Lead sponsor
- Cairo University
- Conditions
- Healthy Individuals
- Interventions
- Aerobic exercise Training, Sleep hygiene education
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sleep Quality (PSQI Global Score) | Baseline (Pre-intervention) and Post-intervention (Week 6) | Pittsburgh Sleep Quality Index (PSQI) Global Score (scale range: 0 to 21, where lower scores indicate better sleep quality). |
| Secondary | Overall Stability Index (OSI) | Baseline (pre-intervention) and post-intervention (at 6 weeks) | Overall Stability Index (OSI) measured using the Biodex Balance System (scale range: 0 to higher values, where higher scores indicate greater postural instability and worse outcome) |
| Secondary | Insomnia Severity Index (ISI) | Baseline (pre-intervention) and post-intervention (at 6 weeks) | Assesses the nature, severity, and impact of insomnia symptoms over the past two weeks using a 7-item self-report questionnaire, with total scores ranging from 0 to 28 (where higher scores indicate greater insomnia severity and worse outcome). |
| Secondary | Generalized Anxiety Symptoms (GAD-7) | Baseline (pre-intervention) and post-intervention (at 6 weeks) | Measures the severity of generalized anxiety symptoms over the past two weeks using a 7-item scale, with total scores ranging from 0 to 21 (where higher scores indicate greater anxiety severity and worse outcome). |
| Secondary | Mindfulness Attention Awareness Scale (MAAS) | Baseline (pre-intervention) and post-intervention (at 6 weeks) | Measures the general tendency to be attentive to and aware of present-moment experiences in daily life using the 15-item Mindful Attention Awareness Scale, with total scores ranging from 15 to 105 (where higher scores indicate greater mindfulness and better outcome). |
| Secondary | Anterior-Posterior Stability Index (APSI) | Baseline (pre-intervention) and post-intervention (at 6 weeks) | Anterior-Posterior Stability Index (APSI) measured using the Biodex Balance System (scale range: 0 to higher values, where higher scores indicate greater instability and worse outcome |
| Secondary | Medial-Lateral Stability Index (MLSI) | Baseline (pre-intervention) and post-intervention (at 6 weeks) | Medial-Lateral Stability Index (MLSI) measured using the Biodex Balance System (scale range: 0 to higher values, where higher scores indicate greater instability and worse outcome) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909980
GET https://conductscience.org/api/trials/v1/NCT07909980/registered